Adero Partners’s CVS Health CVS Stock Holding History

Adero Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,476	Closed	-$231K	–	167
2022 Q4	$231K	Buy	2,476 +202	+9%	+$19.5K	0.03%	143
2022 Q3	$216K	Buy	+2,274	New	+$225K	0.03%	143

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Adero Partners's CVS Position: Q1 2023 in Review

Adero Partners sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,476 shares — an estimated $231K sold.

Adero Partners first reported a position in CVS in Q3 2022 and held it in 2 quarters. The position peaked at $231K in Q4 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Adero Partners reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Adero Partners sold 2,476 CVS Health shares in Q1 2023, an estimated $231K.
Adero Partners first reported a position in CVS Health in Q3 2022 and held it in 2 quarters.
Adero Partners's CVS Health position peaked at $231K in Q4 2022.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Adero Partners's 13F filing for Q1 2023, filed 4 May 2023.